Massive diabetes registry aims to unlock secrets of metabolic disease
NCT ID NCT07206875
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This 10-year observational study will follow 10,000 adults with diabetes, metabolic disorders, and related conditions like high blood pressure and fatty liver disease. Researchers will collect routine medical data to identify markers of disease severity and activity. The goal is to improve how these conditions are diagnosed, monitored, and treated in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help doctors better understand and manage diabetes and related conditions, leading to improved diagnosis and treatment approaches.
- What could go wrong
- This is an observational study, not a treatment trial. It collects data only and does not test any new drug or therapy, so it cannot directly lead to a cure or new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Diabetology Department, San Raffaele Scientific Institute
Milan, Italy, 20132, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a blood flow 'Tourniquet' workout repair diabetic nerve damage?
- Could a common diabetes drug weaken your bones?
- Can a spice and a mindset shift ease diabetic nerve pain?
- Ancient wisdom meets modern care: could chinese medicine boost diabetes Self-Management?
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?
- Could a peptide injection help rebuild Insulin-Making cells?